Epratuzumab for Systemic Lupus Erythematosus von Wallace, DJ, Goldenberg, DM

Volltext

Targeted Therapy of Cancer with Radiolabeled Antibodies von Goldenberg, David M

Volltext

Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy von GOLDENBERG, David M, SHARKEY, Robert M, PAGANELLI, Giovanni, BARBET, Jacques, CHATAL, Jean-Francois

Volltext

Abstract P2-04-17: Directing NK cells to Trop-2-expressing breast and other cancers, with chimeric antigen receptors von Chang, C-H, Liu, D, Goldenberg, DM

Volltext

Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies von Sharkey, Robert M, Goldenberg, David M

Volltext

Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre... von Wallace, Daniel J, Gordon, Caroline, Strand, Vibeke, Hobbs, Kathryn, Petri, Michelle, Kalunian, Kenneth, Houssiau, Frederic, Tak, Paul P, Isenberg, David A, Kelley, Lexy, Kilgallen, Brian, Barry, Anna N, Wegener, William A, Goldenberg, David M

Volltext

Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen) von BLUMENTHAL, Rosalyn D, HANSEN, Hans J, GOLDENBERG, David M

Volltext

Stably Tethered Multifunctional Structures of Defined Composition Made by the Dock and Lock Method for Use in Cancer Targeting von Rossi, Edmund A., Goldenberg, David M., Cardillo, Thomas M., McBride, William J., Sharkey, Robert M., Chang, Chien-Hsing

Volltext

Abstract OT2-07-05: A phase III, randomized trial of sacituzumab govitecan (IMMU-132) vs treatment of physician choice (TPC) for metastatic triple-negative breast cancer (mTNBC) von Bardia, A, Rugo, HS, Horne, H, Wegener, WA, Goldenberg, DM, O'Shaughnessy, J

Volltext

Sphingolipid targets in cancer therapy von Modrak, David E, Gold, David V, Goldenberg, David M

Volltext

Advancing role of radiolabeled antibodies in the therapy of cancer von Goldenberg, David M

Volltext

Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French En... von CHATAL, Jean-Francois, CAMPION, Loïc, BARBET, Jacques, KRAEBER-BODERE, Francoise, BARDET, Stephane, VUILLEZ, Jean-Philippe, CHARBONNEL, Bernard, ROHMER, Vincent, CHANG, Chien-Hsing, SHARKEY, Robert M, GOLDENBERG, David M

Volltext

THU0288 IMMU-115 (Humanized Anti-CD74 Antibody) for Subcutaneous (SC) Administration: A Phase Ib Study in Patients with Systemic Lupus Erythematosus (SLE) von Wallace, D.J., Weisman, M.H., Wegener, W.A., Horne, H., Goldenberg, D.M.

Volltext

New MUC1 Serum Immunoassay Differentiates Pancreatic Cancer From Pancreatitis von GOLD, David V, MODRAK, David E, ZHILIANG YING, CARDILLO, Thomas M, SHARKEY, Robert M, GOLDENBERG, David M

Volltext

Combination Antibody Therapy With Epratuzumab and Rituximab in Relapsed or Refractory Non-Hodgkin's Lymphoma von LEONARD, John P, COLEMAN, Morton, KOVACS, Jacqueline, DING, Cliff L, WEGENER, William A, HORAK, Ivan D, GOLDENBERG, David M, KETAS, Jamie, ASHE, Michelle, FIORE, Jennifer M, FURMAN, Richard R, NIESVIZKY, Ruben, SHORE, Tsiporah, CHADBURN, Amy, HOME, Heather

Volltext

Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-H... von STEIN, Rhona, ZHENGXING QU, CHEN, Susan, ROSARIO, Adriane, SHI, Victoria, HAYES, Marianne, HORAK, Ivan D, HANSEN, Hans J, GOLDENBERG, David M

Volltext

Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines von WASKEWICH, Chris, BLUMENTHAL, Rosalyn D, HONGLAN LI, STEIN, Rhona, GOLDENBERG, David M, BURTON, Jack

Volltext

Abstract P6-15-02: Synthetic lethality in TNBC mediated by an anti-Trop-2 antibody-drug conjugate, sacituzumab govitecan (IMMU-132), when combined with paclitaxel or the PARP inhib... von Goldenberg, DM, Cardillo, TM, Govindan, SV, Zalath, M, Arrojo, R, Sharkey, RM

Volltext

Phase I/II Trial of Epratuzumab (Humanized Anti-CD22 Antibody) in Indolent Non-Hodgkin’s Lymphoma von LEONARD, John P, COLEMAN, Morton, GAYKO, Urte, CESANO, Alessandra, GOLDENBERG, David M, KETAS, Jamie C, CHADBURN, Amy, ELY, Scott, FURMAN, Richard R, WEGENER, William A, HANSEN, Hans J, ZICCARDI, Heather, ESCHENBERG, Michael

Volltext

Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody von Goldenberg, David M, Sharkey, Robert M, Cardillo, Thomas M, Rossi, Edmund A, Chang, Chien-Hsing, Karacay, Habibe, McBride, William J, Hansen, Hans J, Horak, Ivan D

Volltext